RVdb-Rhinovirus Database

Basic information

Title	ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions.
Author	Bourdin, Arnaud; Bjermer, Leif; Brightling, Christopher; Brusselle, Guy G; Chanez, Pascal; Chung, Kian Fan; Custovic, Adnan; Diamant, Zuzana; Diver, Sarah; Djukanovic, Ratko; Hamerlijnck, Dominique; Horvath, Ildiko; Johnston, Sebastian L; Kanniess, Frank; Papadopoulos, Nikos; Papi, Alberto; Russell, Richard J; Ryan, Dermot; Samitas, Konstantinos; Tonia, Thomy; Zervas, Eleftherios; Gaga, Mina
Journal	Eur Respir J	Publication Year/Month	2019-Sep
PMID	31467120	PMCID	-N/A-
Affiliation + expend	1.Universite de Montpellier, CHU Montpellier, PhyMedExp, INSERM, CNRS, Montpellier, France.
	2.Dept of Respiratory Medicine and Allergy, Lung and Allergy research Unit, Lund, Sweden.
	3.Dept of Infection, Immunity and Inflammation, Institute for Lung Health, NIHR BRC Respiratory Medicine, University of Leicester, Leicester, UK.
	4.Dept of Respiratory Diseases, Ghent University Hospital, Ghent, Belgium.
	5.University of Marseille, Marseille, France.
	6.National Heart and Lung Institute, Imperial College, London, UK.
	7.Dept of Paediatrics, Imperial College London, London, UK.
	8.Dept of Respiratory Medicine and Allergology, Skane University Hospital, Lund, Sweden.
	9.Respiratory and Allergy Research, QPS Netherlands, The Netherlands.
	10.Dept of Respiratory Sciences, College of Life Sciences, Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, UK.
	11.University Hospital Southampton NHS Foundation Trust, Southampton, UK.
	12.Amsterdam, The Netherlands.
	13.National Koranyi Institute for Pulmonology, and Dept of Public Health, Semmelweis University, Budapest, Hungary.
	14.Dept of Respiratory Medicine, Imperial College London, London, UK.
	15.Reinfeld, Germany.
	16.Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
	17.Allergy Dept, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
	18.Respiratory Medicine, University of Ferrara, Ferrara, Italy.
	19.Institute for Lung Health, NIHR Leicester Biomedical Research Centre, Dept of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
	20.Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
	21.Woodbrook Medical Centre, Loughborough, UK.
	22.7th Resp. Med. Dept and Asthma Centre, Athens Chest Hospital, Athens, Greece.
	23.Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
	24.7th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece.
	25.7th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece minagaga@yahoo.com.

Abstract

Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent serious outcomes such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial healthcare costs and psychological burden, including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a task force to search for a clear definition of severe exacerbations, and to also define research questions and priorities. The statement includes comments from patients who were members of the task force.

MeSH terms

Asthma/economics/psychology/*therapy

*Disease Progression

Pulmonary Medicine/organization & administration/*standards

Adult

Anxiety

Europe

Female

Health Care Costs

Humans

Male

Medication Adherence

Models, Theoretical

Risk Factors

Societies, Medical

Publication